Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Bugianesi

Showing results (131-140 of 326) with videos related to

Pageof 33
Sort By:
Alimentary Pharmacology & Therapeutics|October 16, 2024
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE TrialPhilip N Newsome, Arun J Sanyal, Kristiane A Engebretsen, et al.
Hepatology (Baltimore, Md.)|April 21, 2025
Erratum: Late breaking abstractsPhilip Newsome, Arun Sanyal, Iris Kliers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2013
Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver diseasePaul Angulo, Jacob George, Christopher P Day, et al.
Journal of Clinical Gastroenterology|October 17, 2022
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic SteatohepatitisIra M Jacobson, Vincent Wai-Sun Wong, Laurent Castera, et al.
Nature Metabolism|July 23, 2020
The next decade of metabolismFredrik Bäckhed, Elisabetta Bugianesi, Heather Christofk, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2005
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severityElisabetta Bugianesi, Uberto Pagotto, Rita Manini, et al.
Cells|December 22, 2019
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic MyofibroblastsBeatrice Foglia, Salvatore Sutti, Dario Pedicini, et al.
Hepatology (Baltimore, Md.)|July 8, 2009
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis CEster Vanni, Maria Lorena Abate, Elena Gentilcore, et al.
Gut|October 23, 2010
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis CGianluca Svegliati-Baroni, Graziella Faraci, Luca Fabris, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2015
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitisChiara Rosso, Gian Paolo Caviglia, Maria Lorena Abate, et al.
Pageof 33

Showing results (131-140 of 326) with videos related to

Sort By:
Pageof 33
Alimentary Pharmacology & Therapeutics|October 16, 2024
Semaglutide 2.4 mg in Participants With Metabolic Dysfunction-Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 ESSENCE TrialPhilip N Newsome, Arun J Sanyal, Kristiane A Engebretsen, et al.
Hepatology (Baltimore, Md.)|April 21, 2025
Erratum: Late breaking abstractsPhilip Newsome, Arun Sanyal, Iris Kliers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2013
Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver diseasePaul Angulo, Jacob George, Christopher P Day, et al.
Journal of Clinical Gastroenterology|October 17, 2022
Expert Panel Consensus on Clinical Assertion Statements Describing Noninvasive Tools for Diagnosing Nonalcoholic SteatohepatitisIra M Jacobson, Vincent Wai-Sun Wong, Laurent Castera, et al.
Nature Metabolism|July 23, 2020
The next decade of metabolismFredrik Bäckhed, Elisabetta Bugianesi, Heather Christofk, et al.
The Journal of Clinical Endocrinology and Metabolism|March 31, 2005
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severityElisabetta Bugianesi, Uberto Pagotto, Rita Manini, et al.
Cells|December 22, 2019
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic MyofibroblastsBeatrice Foglia, Salvatore Sutti, Dario Pedicini, et al.
Hepatology (Baltimore, Md.)|July 8, 2009
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis CEster Vanni, Maria Lorena Abate, Elena Gentilcore, et al.
Gut|October 23, 2010
Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis CGianluca Svegliati-Baroni, Graziella Faraci, Luca Fabris, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 31, 2015
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitisChiara Rosso, Gian Paolo Caviglia, Maria Lorena Abate, et al.
Pageof 33